• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Single-cell tumour phylogenetics

by
October 26, 2026
in Cancer
Reading Time: 2 mins read
0
Single-cell tumour phylogenetics

Single-cell tumour phylogenetics

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A review published in Nature Reviews Cancer on 26 October 2026 examines how single-cell genomics has entered cancer research and clinical oncology, enhancing our understanding of somatic evolution and the genomic heterogeneity that exists inside a tumour. Written by Johannes Gawron, Jack Kuipers, Ang Li, Benjamin J. Raphael, Florian Markowetz and Niko Beerenwinkel, the article frames the evolutionary history of a tumour as a phylogenetic tree and surveys the statistical and computational methods that researchers have proposed in recent years to reconstruct such trees from single-cell sequencing data.

The central argument of the review is that tumour phylogenetics cannot simply borrow from classical evolutionary biology. According to the authors, the nature of tumour evolution, combined with the characteristics of single-cell sequencing itself, raises modelling challenges that classical phylogenetic and phylodynamic approaches were not designed to address. The review therefore walks readers through the models and assumptions behind bespoke single-cell tumour phylogeny methods, explaining how each framework represents the somatic events that accumulate as a tumour evolves and where those representations can break down.

A substantial portion of the article is devoted to recent computational and algorithmic advances in phylogenetic inference. The authors compare different ways of representing mutation histories, highlighting how the choice of representation shapes what an inferred tree can reveal about the evolutionary events in a tumour. They also examine how unaccounted-for genomic events or sequencing errors can affect phylogenetic tree reconstruction, and they describe the tree inference strategies that researchers have developed for single-cell data. Together, these sections map the technical landscape that determines how faithfully a reconstructed tree reflects the underlying biology.

The practical payoff of these methods extends across basic and clinical oncology research. By applying single-cell phylogenetic reconstruction to individual cancers and to cohorts of patient samples, researchers can gain new insights into how tumours diversify and how subpopulations of cells relate to one another. The review discusses these applications in detail, positioning tumour phylogenetics as a bridge between the data-rich world of single-cell genomics and the evolutionary questions that underpin cancer progression.

The authors close with an outlook on the current challenges facing single-cell phylogenetics and its potential future applications. As single-cell sequencing continues to spread through cancer research, the review offers a structured guide to a field that is defining how the evolutionary history of cancer can be read directly from its cells, while also setting out the open problems that will shape the next phase of method development.

Subject of Research: Computational methods for reconstructing tumour phylogenies from single-cell sequencing data

Article Title: Single-cell tumour phylogenetics

Article References: Gawron, J., Kuipers, J., Li, A., Raphael, B. J., Markowetz, F., & Beerenwinkel, N. (2026). Single-cell tumour phylogenetics. Nature Reviews Cancer. https://doi.org/10.1038/s41568-026-00992-2

Image Credits: AI Generated

DOI: 10.1038/s41568-026-00992-2

Keywords: single-cell genomics, tumour phylogenetics, cancer evolution, intra-tumour heterogeneity, somatic evolution, phylogenetic inference, computational biology, Nature Reviews Cancer, Single-cell, tumour, phylogenetics, scientific research

News Source: Nathaniel Bowman. (October 26, 2026). Single-cell tumour phylogenetics. Scienmag.

Tags: cancer evolutioncomputational biologyintra-tumour heterogeneityNature Reviews Cancerphylogenetic inferencephylogeneticsscientific researchsingle-cellSingle-Cell Genomicssomatic evolutiontumourtumour phylogenetics
Share12Tweet7Share2ShareShareShare1

Related Posts

Endothelial p16 expression marks a favorable-prognosis subgroup of clear cell renal cell carcinoma

Endothelial p16 expression marks a favorable-prognosis subgroup of clear cell renal cell carcinoma

October 26, 2026
Review Reframes MAD Genes as a Coordinated Genome Stability Axis in Cancer

Review Reframes MAD Genes as a Coordinated Genome Stability Axis in Cancer

October 26, 2026

Beta-1 blocker use linked to higher mortality in immune checkpoint inhibitor patients

October 26, 2026

PTN-Secreting Glioblastoma Subclone Rebuilds the Immune Niche to Seed Distant Recurrence

October 26, 2026

POPULAR NEWS

  • Endothelial p16 expression marks a favorable-prognosis subgroup of clear cell renal cell carcinoma

    Endothelial p16 expression marks a favorable-prognosis subgroup of clear cell renal cell carcinoma

    29 shares
    Share 12 Tweet 7
  • Two decades of Mendelian randomization mapped: pleiotropy tops the field’s methodological worries

    29 shares
    Share 12 Tweet 7
  • Vision Transformer Reads Persian Miniatures With 93.85% Accuracy in Style Classification Test

    29 shares
    Share 12 Tweet 7
  • Nerve Block Tames Blood Pressure Spikes During Adrenal Tumor Surgery, Trial Finds

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Endothelial p16 expression marks a favorable-prognosis subgroup of clear cell renal cell carcinoma

Two decades of Mendelian randomization mapped: pleiotropy tops the field’s methodological worries

Vision Transformer Reads Persian Miniatures With 93.85% Accuracy in Style Classification Test

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.